¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"time constant of a reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • bleeding time
    ÃâÇ÷½Ã°£
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • breath holding time
    ¼ûÂü´Â½Ã°£, È£ÈíÁßÁö½Ã°£
  • circulation time
    ¼øÈ¯½Ã°£
  • clot retraction time
    ÇǶ±µÞ´ç±è½Ã°£, Ç÷º´¼öÃà½Ã°£
  • clotting time
    ÀÀ°í½Ã°£
  • coagulation time
    ÀÀ°í½Ã°£
  • colonic transit time
    ´ëÀåÅë°ú½Ã°£
  • concentration-time curve
    Ç÷Áß³óµµ°î¼±
  • conduction time
    Àüµµ½Ã°£
  • dead time
    ºÒÀÀ½Ã°£
  • diastolic filling time
    È®Àå±âÃæ¸¸½Ã°£
  • diffusion time
    È®»ê½Ã°£
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • initial reaction
    Ãʱâ¹ÝÀÀ
  • late reaction
    (¢¡delayed reaction) Áö¿¬¹ÝÀÀ
  • periosteal reaction
    »À¸·¹ÝÀÀ, °ñ¸·¹ÝÀÀ
  • phobic reaction
    °øÆ÷¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • reversible reaction
    °¡¿ª¹ÝÀÀ
  • second order reaction
    ÀÌÂ÷¹ÝÀÀ
  • second set reaction
    ÀÌÂ÷°ÅºÎ¹ÝÀÀ
  • setting reaction
    ÀÀ°í¹ÝÀÀ
  • skin reaction
    ÇǺιÝÀÀ
  • static reaction
    Á¤Àû¹ÝÀÀ, ÆòÇü¹ÝÀÀ
  • stress reaction
    ½ºÆ®·¹½º¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • universal gravitation constant
    ¸¸À¯Àη»ó¼ö
  • velocity constant
    ¼Óµµ»ó¼ö
  • acquisition time
    ȹµæ½Ã°£
  • activated coagulation time
    Ȱ¼ºÇ÷¾×ÀÀ°í½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • atrioventricular conduction time
    ¹æ½ÇÀüµµ½Ã°£
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • bleeding time
    ÃâÇ÷½Ã°£
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • breath holding time
    ¼ûÂü´Â½Ã°£
  • lead-time bias
    Á¶±â¹ß°ß±â°£¹ÙÀ̾
  • clot retraction time
    Ç÷º´ÅðÃà½Ã°£, Çǵ¢À̵ڴç±è½Ã°£
  • clotting time
    (¢¡coagulation time) ÀÀ°í½Ã°£
  • coagulation time
    ÀÀ°í½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gastric emptying time
    À§(³»¿ë)¹èÃâ½Ã°£.
  • generation time =doubling t.
    ¼¼´ë½Ã°£(á¦ÓÛãÁÊà), ¹èÀ§½Ã°£(ÛÃêÈãÁÊà), ¼¼´ë±â(á¦ÓÛÑ¢).
  • half survival time
    ¹Ý°¨ÀÜ»ý¼ö¸í(ËÑ˧ ËÛËÎ).
  • half survival time
    ¹Ý°¨ÀÜ»ý¼ö¸í(ÚâÊõíÑßæáøÙ¤).
  • half time for saturation
    ¹ÝÆ÷È­±â(ÚâøéûúÑ¢).
  • hardening time
    °æÈ­½Ã°£(¡­ãÁÊà).
  • inertia time
    Ÿ¼º½Ã°£(öçàõãÁÊà)
  • influx time
    À¯ÀԽð£(êüìýãÁÊà).
  • inspiratory pause time
    Èí±âÈÄÈÞÁö½Ã°£.
  • inspiratory phase time
    Èí±â»ó½Ã°£.
  • inspiratory triggering response time
    Èí±âÀ¯¹ß¹ÝÀÀ½Ã°£.
  • persistence time
    Áö¼Ó½Ã°£(ò¥áÙãÁÊà).
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • polymerizing time
    ±»´Â ½Ã°£ (ÁßÇÕ ½Ã°£)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin Constant Spring
    ÄÁ½ºÅÏÆ® ½ºÇÁ¸µ Ç÷»ö¼Ò
  • ionization constant
    ÀÌ¿ÂÈ­»ó¼ö(¡­ßÈâ¦).
  • kerma rate constant
    Ä¿¸¶À²»ó¼ö
  • mean corpuscular constant =MCC
    Æò±ÕÀûÇ÷±¸»ó¼ö(?ËøÌ´Ë´Ë×?).
  • mean corpuscular constant =MCC
    Æò±ÕÀûÇ÷±¸»ó¼ö(¡­îåúìϹßÈâ¦).
  • permeability constant
    Åõ°ú»ó¼ö(¡­ßÈâ¦).
  • phase constant
    À§»ó»ó¼ö(êÈßÓßÈâ¦).
  • polarization constant
    ºÐ±Ø»ó¼ö(ÝÂпßÈâ¦).
  • quantum constant
    ¾çÀÚ»ó¼ö(åÖí­ßÈâ¦).
  • radioactive constant
    ¹æ»ç´É»ó¼ö
  • sedimentation constant
    ħ°­»ó¼ö( ˽ ßÈâ¦).
  • space constant
    °ø°£»ó¼ö(¡­ßÈâ¦).
  • specific gas constant
    ºñ±âü»ó¼ö(ÝïѨô÷ ßÈâ¦).
  • spin spin coupling constant(J)
    ½ºÇɽºÇÉ Ä¿Çøµ(°áÇÕ) »ó¼ö(J)
  • statistical constant
    Åë°è»ó¼ö(̬˭Ë×Ëà).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • formation constant
    Çü¼º »ó¼ö(û¡à÷ßÈâ¦)
  • gas constant
    ±âü »ó¼ö (Ѩô÷ßÈâ¦)
  • growth rate constant
    ¼ºÀå¼Óµµ »ó¼ö (à÷íþáÜÓøßÈâ¦)
  • hydrolysis constant
    °¡¼öºÐÇØ(Ê¥â©ÝÂú°) »ó¼ö(ßÈâ¦)
  • hydrophobicity constant
    ¼Ò¼ö¼º »ó¼ö(áÂâ©àõßÈâ¦)
  • rate constant
    ¼Óµµ»ó¼ö(áÜÓøßÈâ¦)
  • inhibition constant
    ÀúÇØ»ó¼ö(îÁúªßÈâ¦)
  • inhibitor constant
    ÀúÇØÁ¦»ó¼ö(îÁúªð¥ßÈâ¦)
  • intrinsic association constant
    °íÀ¯ ¿¬ÇÕ»ó¼ö(ͳêóÖ¤ùêßÈâ¦)
  • intrinsic dissociation constant
    °íÀ¯ ÇØ¸®»ó¼ö(ͳêóú°×îßÈâ¦)
  • ionization constant
    ÀÌ¿ÂÈ­(ûù) »ó¼ö(ßÈâ¦)
  • kinetic constant
    ¹ÝÀÀ¼Óµµ»ó¼ö(ÚãëëáÜÓøßÈâ¦)
  • law of constant heat summation
    Á¾ÇÕ¿­ºÒº¯¹ýÄ¢(ðüùêæðÝÕܨÛööÎ)
  • macroscopic binding constant
    °Å½Ã °áÇÕ»ó¼ö(ËÝãÊÌ¿ùêßÈâ¦)
  • Michaelis constant
    ¹ÌŰ¿¤¸®½º»ó¼ö(ßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • real time system
    ½Ç½Ã°£Ã¼°è
  • recovery time
    ȸº¹±â°£, ȸº¹ ½Ã°£
  • relaxation time
    À̿Ͻð£
  • repetition time [=TR]
    ¹Ýº¹½Ã°£
  • ring down time
    ¿©¿î½Ã°£
  • rise time
    »ó½Â½Ã°£
  • rising time
    »ó½Â½Ã°£
  • scan time
    ÁÖ»ç½Ã°£
  • spin lattice relaxation time (T1)
    ½ºÇɰÝÀÚÀ̿Ͻð£(T1)
  • spin spin relaxation time
    ½ºÇɽºÇÉÀ̿Ͻð£
  • T.G.C [=time gain compensation]
    ½Ã°£°ÔÀκ¸»ó
  • T1 relaxation time
    T1À̿Ͻð£
  • T2 (spin spin) relaxation time
    T2(½ºÇɽºÇÉ)À̿Ͻð£
  • T2 relaxation time
    T2À̿Ͻð£
  • temporal window(scan time)
    ÀϽÃÀû â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
AAR active avoidance reaction; acute articular rheumatism; antigen-antiglobulin reaction
APR abdominoperineal resection; absolute proximal reabsorption; acute phase reaction or reactant; amebic...
CFR case-fatality ratio; citrovorum-factor rescue; Code of Federal Regulations; complement-fixation reac...
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
FW Felix-Weil [reaction]; Folin-Wu [reaction]; fragment wound
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CF constant frequency
CMF constant magnetic field
IC50 inhibition constant
LC lumped constant
TE time , expiratory time
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • prolonged bleeding time
    ¿¬ÀåµÈ ÃâÇ÷ ½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • real time image
    ½Ç½Ã°£ ¿µ»ó
  • real time study
    ½Ç½Ã°£ °Ë»ç
  • relaxation time
    ÀÌ¿Ï ½Ã°£
  • retention time
    ÀÜ·ù ½Ã°£
  • setting time
    °æÈ­ ½Ã°£, ÀÀ°í ½Ã°£, ±»´Â ½Ã°£
    1. ºñÄÏ Ä§À» »ç¿ëÇÏ¿© ¿¬È­ °³½Ã¿¡¼­ ħÀÔ±íÀ̰¡ 1§® ÀÌÇϰ¡ µÉ ¶§±îÁöÀÇ ½Ã°£À» °æÈ­ ½Ã°£À̶ó ÇÑ´Ù. ¾ö¹ÐÈ÷ Ãʱ⠰æÈ­ ½Ã°£ÀÌ´Ù. 2. È¥ÇÕ ½ÃÀÛºÎÅÍ Àç·á°¡ ÃæºÐÇÏ¿© ÀÓ»óÀûÀ¸·Î À¯ÀǼºÀÌ ÀÖ´Â ¿µ±¸ º¯Çü ¾øÀÌ ÀλóÀ» ±¸°­ ³»¿¡¼­ Á¦°ÅÇÒ ¼ö Àִµ¥ ¼Ò¿äµÇ´Â ÃÖ¼ÒÇÑÀÇ ½Ã°£.
  • T2 relaxation time
    T2 ÀÌ¿Ï ½Ã°£
  • T2 spin spin relaxation time
    T2 ½ºÇÉ ½ºÇÉ ÀÌ¿Ï ½Ã°£
  • thermal camera time response
    ¿­ Ä«¸Þ¶ó ½Ã°£ ¹ÝÀÀ
  • time
    ½Ã°£, ¶§
    ¾î¶² ½Ã°¢°ú ½Ã°¢ÀÇ »çÀÌ.
  • time cycled ventilator
    ½Ã°£ ÁÖ±â È£Èí±â
  • time difference
    ½ÃÂ÷
  • time gain compensation
    ½Ã°£ °ÔÀÎ º¸»ó
  • time gain control
    ½Ã°£ °ÔÀÎ Á¶Àý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
P-A conduction time See: atrioventricular conduction.
(05 Mar 2000)
generation time <cell biology> Time taken for a cell population to double in numbers and thus equivalent to the average length of the cell cycle.
(18 Nov 1997)
real-time ultrasonography Rapid serial ultrasound images produced using a phased array or scanning transducer; produces a video display of organ motion, such as heart valve or foetal motion.
(05 Mar 2000)
recognition time The interval between the application of a stimulus and the recognition of its nature.
(05 Mar 2000)
partial thromboplastin time Test of the intrinsic (factors viii, ix, xi, and xii) and common (fibrinogen, prothrombin, factors v and x) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy.
(12 Dec 1998)
relaxation time Time taken for a system to return to the resting or ground state or a new equilibrium state following perturbation. Often used in context of receptor systems that have a refractory period after responding and then relax to a competent state. Can be used more precisely to mean the time for a system to change from its original equilibrium value to 1/e of this original value.
(18 Nov 1997)
median time to elimination <pharmacology> The time it takes one half of a drug to be eliminated from the body.
(09 Oct 1997)
repetition time In magnetic resonance imaging, the time between repetitions of the pulse sequence.
(05 Mar 2000)
rise time The time required for a pulse or echo to rise from 10% to 90% of its peak amplitude.
(05 Mar 2000)
P-H conduction time See: atrioventricular conduction.
(05 Mar 2000)
running time The time during which an activity (e.g., chromatography development) occurs.
(05 Mar 2000)
Russell's viper venom clotting time A clotting time determination performed on citrated platelet-poor plasma using Russell's viper venom as an activating agent. This allows activation of factor X directly without the need for other coagulation factors and is used to confirm factor X defects.
See: Stypven time test.
(05 Mar 2000)
circulation time The time taken for the blood to pass through a given circuit of the vascular system, e.g., the pulmonary or systemic circulation, from one arm to another, from arm to tongue, or from arm to lung; it is measured by the injection into an arm vein of a substance, such as sodium dehydrocholate, ether, fluorescein, histamine, or a radium salt, which can be detected when it arrives at another point in the vascular system.
(05 Mar 2000)
clot retraction time The time required for a blood clot to separate from the tube wall and express serum, usually completed in 18 to 24 hours, but retarded or absent in persons with thrombocytopenic purpura.
(05 Mar 2000)
clotting time The time required for blood to coagulate; prolonged in haemophilia and in the presence of obstructive jaundice, some anaemias and leukaemias, and some of the infectious diseases.
Synonym: clotting time.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • time
    ½Ã°£,°èÀý,(º¹¼ö)½Ã´ë,-ȸ(¹è)
  • Central (Standard) Time
    ÁߺΠǥÁؽÃ(G.M.T.º¸´Ù 6½Ã°£ ´ÊÀ½)
  • Double Summer Time
    ÀÌÁß ¼­¸ÓŸÀÓ(Ç¥Áؽ𣺸´Ù 2½Ã°£ ºü¸§)
  • Eastern Standard time
    µ¿ºÎ Ç¥ÁؽÃ(ij³ª´Ù µ¿ºÎ,¹Ì±¹ µ¿ºÎ,¿À½ºÆ®·¹Àϸ®¾Æ µ¿¹«)
  • Father Time
    ½Ã°£ ÇҾƹöÁö
  • Greenwich (Mean(Civil)time
    ±×¸®´ÏÄ¡ Ç¥ÁؽÃ
  • Greenwich Mean Time
    ±×¸®´ÏÄ¡ Ç¥ÁؽÃ
  • Hawaii time
    =Hawaiian Standard TimeÇÏ¿ÍÀÌ Ç¥ÁؽÃ(GMEº¸´Ù 10½Ã°£ ´Ê°í ½Ã°£´ë´Â Alaska Time¿Í °°À½
  • Pacific(Standard) Time
    (¹Ì±¹ÀÇ) ÅÂÆò¾ç Ç¥ÁؽÃ
  • T-time
    ·ÎÄÏ ¹ß»ç ½Ã°£
  • Time Square
    New York ½ÃÀDZØÀå°¡
  • access time
    È£Ãâ½Ã°£(±â¾ï ÀåÄ¡¿¡ Á¤º¸¸¦ ±â·Ï,ÇØµ¶ÄÉ Çϱâ À§ÇÑ ½Ã°£);ÄÄÇ»ÅÍ¿ë¾î
  • apparent time
    (ÇØ½Ã°èµîÀÇ)žçÀÇ À§Ä¡·Î ÃøÁ¤Çϴ½ð£
  • atomic time clock
    ¿øÀÚ ¿¬´ë ½Ã°è
  • atonic time clock
    ¿øÀÚ¿¬´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á